A process is disclosed for the preparation of a hydroxyl apatite material by means of hydrothermal conversion using as starting material a calcitic skeleton which has been purified of organic substances. The conversion is carried out under saturated steam pressure, preferably at a temperature in the range of from 100°C to 250°C The influence of the reaction, or rather the defect density of the materials is preferably achieved by the addition of fluoride ions. In addition, the adaption of the material to differing implantation areas as hard tissue replacements as well as the preparation of workable compact implants is described.

Patent
   4938938
Priority
Mar 26 1987
Filed
Nov 22 1988
Issued
Jul 03 1990
Expiry
Mar 24 2008
Assg.orig
Entity
Small
46
2
all paid
1. A process for the preparation of a carbonaceous hydroxyl apatite material by means of hydrothermal conversion, comprising the following steps:
(a) cleaning a hard tissue from organic substances,
(b) converting the tissue with an aqueous concentrated solution of (NH4)2 HPO4 solution at a temperature up to 250°C,
(c) executing the conversion in an autoclave under saturation steam pressure, and
(d) during conversion compensating for the content of Mg2+ -ions by addition of F of ions.
2. A process according to claim 1, wherein the pH value of the aqueous solution is adjusted to a predetermined value.
3. A process according to claim 2, wherein the pH value is adjusted to at least 8.5.
4. A process according to claim 1, wherein the hydroxyl apatite material is subjected to an after treatment by tempering.
5. A process according to claim 1, wherein the hydroxyl apatite material is treated with a slurry of a binder material and the indicated process steps for the hydrothermal conversion are then repeated.
6. A process according to claim 5, wherein the binder material is slaked lime and the hydrothermal conversion is carried out after setting of the lime.
7. A process according to claim 5, wherein the hydroxyl apatite material is placed in a mold prior to treatment with the binder material.
8. A process according to claim 1, wherein the hydroxyl apatite material is treated with a slurry of binder material before conversion.
9. A process according to claim 1, wherein the hydroxyl apatite material is placed in a mold.
10. A process according to claim 1, wherein the starting material comprises skeletons of lime-encrusted algae.
11. A process according to claim 1, wherein the starting material comprises an organic, porous hard tissue.
12. A process according to claim 11, wherein the hard tissue is decarbonised prior to the conversion.

The invention relates to a process for the preparation of a carbonaceous hydroxyl apatite material by means of hydrothermal conversion with the addition of an aqueous (NH4)2 HPO4 solution. As starting material a hard tissue purified from organic substances in employed.

Hydroxyl apatite material of this kind is suitable for use as a biocompatible implant, for examle as hard tissue replacements for bones and teeth, since the inorganic portion of human hard tissue in essence is formed of a cryptocrystalline carbonaceous hydroxyl apatite.

A process is known from U.S. Pat. No. 3,929,971 according to which a hydroxyl apatite material is extracted from the aragonitic skeletons of living corrals and starfish by means of hydrothermal treatment. This known process has the disadvantage that the hydrothermal treatment must be carried out at a relatively high temperature under very high presure.

The use of the hydroxyl apatite material as implants has the disadvantage that, with the known process of production, as a result of the temperature, the pressure and the chemical potential of the participating components, high defect densities do not occur, which results in a bone-like difference of the material from the ideal structure of a dense material of the formula Ca10 (PO4)6 (OH)2 with apatite structure. These defect densities can occur for example by the substitution of carbonate CO32- for phosphate PO43- or by stray ions, in particular alkali in cation sublattice form, as well as halogenides in the anion sublattice. Moreover, the products obtained by means of the known process do not attaine desired requirements for deviation of the bone-like cryptocrystallinity with respect to the use as implants.

It is an object of the present invention to provide a process of the above type which, as a result of reduced energy requirements and relatively low pressure, can be carried out in a relatively short time and afford the desired bone-like defect density and cryptocrystallinity. desired bone-like defect density and crypytocrystallinity.

Accordingly, the invention provides a process for the preparation of a carbonaceous hydroxyl apatite material by means of hydrothermal conversion with the adddition of aqueous (NH4)2 HPO4 solution, whereby as starting material an organic substance-free hard tissue is employed, characterized in that the conversion takes place in an autoclave at saturation steam pressure of the respective fluid phase.

Thus, the object is attained by the hydrothermal conversion in an autoclave at saturation stream pressure of the respective fluid phase being employed. The saturation steam pressure is reached if the pressure vessel is not completely filled. Already with operating times of less than 24 hours and a temperature of 200°C, an optimum conversion can be attained.

In a preferred embodiment of thke invention, by means of a controlled adjustment of the pH value of the substitution solution, preferably to at least about 8.5, the formation of other phases than hydroxyl apatite can be suppressed.

In addition, it can also be of advantage to suppress the influence of Mg2+ ions by appropriate addition of fluoride ions. This measure has the advantage that the content of magnesium ions compensates for and thereby hinders the formation of undesired β-tricalcium phosphate (β-Whitlockite). Furthermore, the crystallinity and defect density of the materials, i.e. the real structure of the material and thus the adaption of the material to the implant area, is attained during the synthesis by the addition of fluoride. This leads to an artifical aging or hardening of the material.

Preferably the process is continued by after-treatment of the hydroxyl apatite material by tempering. Also through these measures can the artificial aging or hardening of the materials be attained. As a result of the temperature, the defect density is influenced, while the crystallite size increases with the tempering time.

In particular, for the preparation of a compact implant, it is advantageous to treat the hydroxyl apatite material with a binding material and thereafter to repeat the previously described steps of the hydrothermal treatment. The material obtained in this manner can be worked with conventional tools.

As an alternative, it is also advantageous that the starting material prior to the hydrothermal treatment should be washed with a binding material, followed by the conversion of the starting material and the binder simultaneously. In this manner, the process can be accelerated.

Slaked lime is preferably employed as the binder, and the hydrothermal treatment is carried out after setting of the lime. For shaping the hydroxyl apatite material, it is expedient that the material be disposed in a mold.

It is particularly preferably to place the hydroxyl apatite material in the mould prior to treatment with slaked lime.

It has also proven very advantageous that, as starting material, the skeletons of lime encrusted algae are used. In this manner, a hydroxyl apatite material is obtained which exhibits an extremely fine surface, porosity and cytophilic surface geometry and which is extremely similar to organogenetic material. By means of the synthesis according to the invention the original interconnecting microporosity of the starting material is retained. In clinical testing, it has been shown that the hydroxyl apatite material obatained herein is not only biocompatible, but also bioactive, and that it is not only integrated in the bone building process, but also active in initiating and supporting osteogenesis.

Alternatively, as starting material an organic, porous hard substance (tissue) is very suitable. The hard substance is advantageously decarbonised prior to conversion.

The invention provides a process which ensures, particularly in the temperature range up to 250°C, and at a pressure of up to 40 bar, an efficient conversion with limited material and energy costs. It stands out above all in contrast to hydrothermal syntheses which require the use of external pressure and need high temperature precious metal containers. Apart from this, bone replacement materials can be obtained, which are bone-like and which in view of their crystallite size and their defect density are excellent for use as implants.

The process will now be further described with reference to a specific example.

First the organic components of the starting material were completely removed. In this way the starting material can be decarbonised at a higher temperature. The following process steps were then carried out:

(1) Cleaning of the starting materials.

(1.1) Separating large grain foreign paricles by the use of binoculars.

(1.2) Repeated washing of the starting material with double distilled water, if necessary at elevated temperature.

(2) Roentgenographic determination of the Mg2+ content of the starting material and addition of F- ions to compensate for the Mg+ content. This compensation can be achieved by the addition of NH4 F, alkali fluoride, CaF2, HF or the like.

(3) Synthesis

The starting material is placed in an autoclave having a lining of stable thermoplastic polytetrafluoroethylene (PTFE), and covered with a concentrated aqueous solution of (NH4)2 HPO4. If required, in order to compensate the Mg+ content a suitable fluoride is added, as already described in paragraph 2. The pH value is then adjusted to about 8.5. The autoclave is not completely filled, so that at elevated temperature, the saturation steam pressue can be accommodated. The maximum temperature is about 250°C on account of the lining of the autoclave. Already at about 200°C an optimal conversion can be attained over a time of less than 24 hours.

(4) After-treatment of the material

After the reaction, the pH value is verified (and should have remained unchanged) and the aqueous phase is discarded. The converted hydroxyl apatite material is washed with double distilled water several times and if necessary briefly boiled. Thereafter, the starting material is dried at a temperature above 100°C

(5) Artificial aging or hardening of the hydroxyl apatite material

The crystallinity and defect density of the material, i.e. the real structure of the material and thereby the adaption of the material to the implantation area, will either be attained by the addition of fluoride in the manner described above during the synthesis, or by tempering of the material at a temperature of up to about 500°C Thereby on the one hand the temperature of the "carbonate content" of the probe is influenced and by the temper time the crystallite size increases.

(6) Compaction of the hydroxyl apatite material

The converted starting material will be vibratingly placed in a mold or form and treating with slaked lime (Ca(OH)2). After the setting of the lime, the mold and contents thereof are again subjected to the synthesis steps described in paragraph 3. In this way, the lime-containing binding material is also converted to hydroxyl apatite material.

It is in principle possible to treat the carbonaceous or oxidic starting material directly with binder and in one operation to convert the carbonaceous or oxidic skeleton and the binding material to hydroxyl apatite material. An artificial aging can then follow according to paragraph 5.

By suitable variation in the pressure, the temperature and the chemical potential it is also possible to prepare Whitlockite (β-Ca3 (PO4)2).

Very good results can be obtained with the following process steps:

1. Drying the starting material, that can be of calcitic or aragonitic origin.

2. Pyrolizing the materials; linear heating over 6 hours to 750°C, i.e. to a temperature which lies above the decomposition material of the starting material; holding at this temperature for 6 hours; linear cooling over 6 hours. The process technique particularly essential in this procedure is the gradual heating. This pyrolysis step influences the reaction and the product by positively loosening the crystalline packing.

3. Fractionation of the material using a fractionating column.

4. A conventional PTFE-lined autoclave with a volume of 400 ml is filled halfway with the material obtained in the previous process step. A previously prepared solution of 68 g of (NH4)2 HPO4 and 1 g of NH4 F per 100 ml of H2 O is added to a total filling of the autoclave of 75%. The volume of the autoclave is made large enough so that the concentrated phosphate solution can be added in excess in order to ensure satisfactory saturation during the entire reaction. The excess can easily be calculated empirically.

5. The autoclave is placed in a drying cabinet and left there between 8 and 16 hours at 200°C

6. The autoclave is then placed in water to effect cooling.

7. The entire autoclave contents are then transferred into an Erlenmeyer flask and rinsed several times with generous quantities of water. Thereafter the product is heated twice with a generous quantity of water

8. Drying is frist carried out under infrared light, then further drying in a drying cupboard at 100°C and finally for about 4 hours at 200°C, which at the same time effects a dry-sterilization.

As further process steps it is advantageous to subject the material to decarbonization before conversion. After degassing, the pore space opens up and thereby the surface increases.

It is especially important that the phosphate solution be concentrated, that the pH value lies in the basic range, preferably at a minimum of 8.5, and that the solution is employed in excess, based on the material being treated, so that the concentration of the solution does not fall under the previous limit during the entire reaction and the pH value remains in the previously stated desired range. In this manner, a complete conversion to hydroxyl apatite is achieved, without also obtaining traces of Whitlockite. With magnesium-containing calcitic skeletons as starting material, and by the addition of NH4 F in an amount of at least one gram per 100 ml of phosphate solution, a conversion to Whitlockite is prevented. The carbonaceous hydroxyl apatite obtained in this manner affords advantages for clinical application, for example a lower re-absorbability.

Important process parameters are further given in the single figure of the accompanying drawing, which shows graphically the relationship between water and steam for varying pressure and temperature.

An autoclave known per se consists of a closeable, high pressure metal vessel with a screw-fitting or press-fitting, tightly closing, removable cover, in which an adjustable safety valve, a manometer and a thermometer are located. In the bottom of the autoclave is disposed water, which can be heated from the exterior. The steam pressure increases then in the interior up to the value calibrated on the safety valve. Thereafter, the valve opens and the excess pressure is released.

In summary, the invention provides that, on account of the low temperature and the internally supplied pressure generation under minumum deployment of energy, hydroxyl apatite can be produced. The undesired buildup of other phosphates, such as above all Whitlockite, is minimized through the correct establishment and maintenance of a basic pH value. Through the previously given sufficient concentration of phosphate ions in the fluid phase during the entire reaction time, a complete conversion is attained. Furthermore, by the addition of fluoride ions, the presence of magnesium ions is compensated and in this way also the accumulation of undesired phases is reduced. Through the pyrolysis of material according to the invention, the microporosity is maintained. The specific surface is increased through the decarbonization, as well as the fluoridation, compaction and modification of the carbonate content. An external pressure generation is not necessary. Maceration of the material can also be avoided.

Ewers, Rolf, Kasperk, Christian, Simons, Bruno

Patent Priority Assignee Title
10227697, May 16 2003 Biomet 3i, LLC Surface treatment process for implants made of titanium alloy
10260153, Aug 19 2005 Houghton Technical Corp. Methods and compositions for acid treatment of a metal surface
11015253, May 16 2003 Biomet 3i, LLC Surface treatment process for implants made of titanium alloy
11730856, Sep 01 2014 KYUSHU UNIVERSITY National University Corporation Method of producing product inorganic compound and product inorganic compound
5082803, Sep 21 1989 Asahi Kogaku Kogyo Kabushiki Kaisha Process for producing bone prosthesis
5145520, Aug 29 1989 Kyoto University Bioactive cement
5650176, May 19 1995 Etex Corporation Synthesis of reactive amorphous calcium phosphates
5676976, May 19 1995 Etex Corporation Synthesis of reactive amorphous calcium phosphates
5683461, May 19 1995 Etex Corporation Synthesis of reactive amorphous calcium phosphates
5730598, Mar 07 1997 Zimmer Dental, Inc Prosthetic implants coated with hydroxylapatite and process for treating prosthetic implants plasma-sprayed with hydroxylapatite
5783217, Nov 07 1995 Etex Corporation Low temperature calcium phosphate apatite and a method of its manufacture
5935552, May 11 1995 UOP LLC Crystalline intergrowth molecular sieves
6117456, May 20 1996 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
6139578, May 19 1995 LIFE SCIENCE ENTERPRISES, INC Preparation of cell seeded ceramic compositions
6214368, May 19 1995 Etex Corporation Bone substitution material and a method of its manufacture
6277151, May 20 1996 LIFE SCIENCE ENTERPRISES, INC Cartilage growth from cell seeded ceramic compositions
6287341, May 19 1995 Etex Corporation Orthopedic and dental ceramic implants
6331312, May 19 1995 Etex Corporation Bioresorbable ceramic composites
6338752, Apr 20 2000 Purzer Pharmaceutical Co., Ltd. α-TCP/HAP biphasic cement and its preparing process
6541037, May 19 1995 Etex Corporation Delivery vehicle
6544290, May 19 1995 LIFE SCIENCE ENTERPRISES, INC Cell seeding of ceramic compositions
6881227, Nov 30 1999 LOGON PATENTVERWERTUNGS-VERWALTUNGS GMBH Hydroxylapatite material containing tricalcium phosphate with microporous structure
6953594, Oct 10 1996 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
6969474, Nov 30 1994 Biomet 3i, LLC Implant surface preparation
6972130, Oct 16 1996 LIFE SCIENCE ENTERPRISES, INC Bioceramic compositions
7150879, May 19 1995 Etex Corporation Neutral self-setting calcium phosphate paste
7169317, Nov 30 1994 Biomet 3i, LLC Implant surface preparation
7258898, Nov 16 2000 BIOTOMO PTY LTD Processes for treating coral and coating an object
7517539, Oct 16 1996 LIFE SCIENCE ENTERPRISES, INC Method of preparing a poorly crystalline calcium phosphate and methods of its use
7547399, Nov 30 1994 Biomet 3i, LLC Implant surface preparation
7550091, Nov 30 1994 Biomet 3i, LLC Implant surface preparation
7842300, Jul 31 2002 Dentsply International, Inc. Bone repair putty
7857987, Nov 30 1994 Biomet 3i, LLC Implant surface preparation
8147860, Dec 06 2005 Etex Corporation Porous calcium phosphate bone material
8216359, Apr 15 2004 Etex Corporation Delayed-setting calcium phosphate pastes
8221499, Nov 30 1994 Biomet 3i, LLC Infection-blocking dental implant
8221781, Apr 11 2003 Etex Corporation Osteoinductive bone material
8251700, May 16 2003 Biomet 3i, LLC Surface treatment process for implants made of titanium alloy
8252195, Aug 19 2005 HOUGHTON TECHNICAL CORP Methods and compositions for acid treatment of a metal surface
8454988, Apr 11 2003 Etex Corporation Osteoinductive bone material
8518286, Aug 19 2005 Houghton Technical Corp. Methods and compositons for acid treatment of a metal surface
8545858, Dec 06 2005 Etex Corporation Porous calcium phosphate bone material
8728536, Oct 16 1996 LIFE SCIENCE ENTERPRISES, INC Chemotherapeutic composition using nanocrystalline calcium phosphate paste
8876532, Jul 31 2002 DENTSPLY International Inc. Bone repair putty
9050163, Mar 21 2011 SCHERR, DOUGLAS S ; GOLDBERG, ROGER P Urethral anastomosis device and method
9732428, Aug 19 2005 Houghton Technical Corp. Methods and compositions for acid treatment of a metal surface
Patent Priority Assignee Title
3929971,
4861733, Feb 13 1987 Biomet Manufacturing Corp Calcium phosphate bone substitute materials
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Aug 16 1988SIMONS, BRUNOPROF DR DR ROLF EWERS, GRAF-SPEE-STR 46, D-2300 KIEL 1ASSIGNMENT OF ASSIGNORS INTEREST 0051470008 pdf
Aug 17 1988KASPERK, CHRISTIANPROF DR DR ROLF EWERS, GRAF-SPEE-STR 46, D-2300 KIEL 1ASSIGNMENT OF ASSIGNORS INTEREST 0051470007 pdf
Nov 22 1988Rolf, Ewers(assignment on the face of the patent)
Date Maintenance Fee Events
Dec 10 1993M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Feb 08 1994REM: Maintenance Fee Reminder Mailed.
Mar 02 1994ASPN: Payor Number Assigned.
Dec 22 1997M284: Payment of Maintenance Fee, 8th Yr, Small Entity.
Jan 12 1998SM02: Pat Holder Claims Small Entity Status - Small Business.
Jan 02 2002M285: Payment of Maintenance Fee, 12th Yr, Small Entity.
Jan 22 2002REM: Maintenance Fee Reminder Mailed.
Feb 05 2002ASPN: Payor Number Assigned.
Feb 05 2002RMPN: Payer Number De-assigned.


Date Maintenance Schedule
Jul 03 19934 years fee payment window open
Jan 03 19946 months grace period start (w surcharge)
Jul 03 1994patent expiry (for year 4)
Jul 03 19962 years to revive unintentionally abandoned end. (for year 4)
Jul 03 19978 years fee payment window open
Jan 03 19986 months grace period start (w surcharge)
Jul 03 1998patent expiry (for year 8)
Jul 03 20002 years to revive unintentionally abandoned end. (for year 8)
Jul 03 200112 years fee payment window open
Jan 03 20026 months grace period start (w surcharge)
Jul 03 2002patent expiry (for year 12)
Jul 03 20042 years to revive unintentionally abandoned end. (for year 12)